-
2022-500535-36-00
5
Moderately to severely active ulcerative colitis
-
2022-500537-84-00
5
Moderately to severely active ulcerative colitis
-
2023-505046-26-00
5
2026-05-07
Colon carcinoma
-
2023-507801-32-00
6
2026-04-22
Isolated Subsegmental Pulmonary Embolism
-
2023-504831-42-00
5
2025-06-27
patient with colorectal cancer with hepatic metastasis
-
2024-514899-41-00
4
2024-10-31
Breast cancer
-
2024-511070-68-01
5
2024-09-24
Ampullary adenocarcinoma
-
2022-502155-65-00
5
2024-07-30
Extra pulmonary sarcoidosis
-
2023-505112-38-00
11
2024-07-01
recently active non-infectious intermediate, posterior, and pan-uveiti
-
2022-501119-14-01
4
2024-04-16
Ulcerative Colitis
-
2023-506232-32-00
9
2024-04-08
Multiple recurrences of Clostridioides difficile infection treated wit
-
2023-506885-30-00
5
2024-03-26
Adult patients with intermediate low or mid rectal adenocarcinoma to b
-
2023-504323-25-01
5
2024-03-19
breast cancer
-
2022-500862-93-00
5
2024-02-01
Pulmonary Hypertension
-
2023-504555-27-00
5
2023-11-28
Myelodysplastic syndrome (MDS)
-
2022-502019-12-00
5
2023-09-14
acute myeloid leukemia
-
2022-501831-18-00
4
2023-09-13
Patients with hematologic malignancies and undergoing allogenic hemato
-
2022-501810-77-00
5
2023-09-01
Relapsed or Refractory Marginal Zone Lymphoma
-
2022-502229-16-00
5
2023-06-19
Ventilator acquired pneumonia
-
2022-501494-39-00
5
2023-03-28
Uncontrolled Hypertension IN patients with moderate to severe chronic
-
2022-501335-16-00
10
2023-01-16
Interstitial lung disease
-
2023-504166-37-00
4
2022-02-01
Advanced ovarian, tubal or peritoneal cancer.
-
2023-503265-27-00
5
2023-11-23
Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Co
-
2022-502966-26-01
5
2023-10-27
Sjögren’s syndrome